SIR Executive Director
- As a society and a specialty, we must be more audience-centric in our communications. Each of the many different audiences important to our specialty should understand our value in terms that matter to them, not just in terms of the treatments we provide.
- There must be a clarion call to focus on collaboration, not competition. Even when the stakes and turf wars are at their highest, SIR can gain from collaborating with other organizations to shape the expansion of IR into new clinical areas and patient teams and solidify ourselves as the embedded expert to these organizations.
- We must show how the very essence of IR is agile and modern. Siloed specialties are old-fashioned and expensive; hospitals, insurers and patients want physicians who are flexible and agile. SIR is uniquely positioned to show how IR delivers on the very things modern medicine asks for: better outcomes, less burden on the patient and innovative use of technology with clear patient benefit.
- We need to portray SIR and SIR Foundation as distinct but complementary organizations working in service of IR. Our members are excited about the impact of research on the specialty, but few are clear about the difference in missions between the two organizations or what their dues fund. Highlighting the role of SIR Foundation-funded research reinforces the sustained vision of SIR Foundation and its investment potential for members, patients and other key audiences.